Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTERNATIONAL FLAVORS & FRAGRANCES INCIFF · Entity 3234 | President, Pharma Solutions | April 04, 2025 | April 07, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTERNATIONAL FLAVORS & FRAGRANCES INC
Report date April 04, 2025 · Filed April 07, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,553 |
Ending reported balance
After 2025-04-04 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2025-04-04 · Exercise / conversion · Acquired 1,258 · Balance 9,859 F1: The RSUs convert to Common Stock on a one-for-one basis. Row 2 · 2025-04-04 · Exercise / conversion · Acquired 503 · Balance 10,362 F2: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on May 4, 2022. F1: The RSUs convert to Common Stock on a one-for-one basis. Row 3 · 2025-04-04 · Tax withholding · Disposed 230 · Balance 10,132 F3: Reflects shares withheld for taxes payable upon the vesting of RSUs. Row 4 · 2025-04-04 · Tax withholding · Disposed 579 · Balance 9,553 F3: Reflects shares withheld for taxes payable upon the vesting of RSUs. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 6,206 |
Reported balance
After 2025-04-04 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2025-04-04 · Exercise / conversion · Disposed 503 · Balance 6,206 F1: The RSUs convert to Common Stock on a one-for-one basis. F2: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on May 4, 2022. F4: The RSUs vested on April 4, 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2025-04-04 | Direct | 0 |
Reported balance
After 2025-04-04 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2025-04-04 · Exercise / conversion · Disposed 1,258 · Balance 0 F1: The RSUs convert to Common Stock on a one-for-one basis. |
Filing footnotes · ownership attribution and instrument terms
F1: The RSUs convert to Common Stock on a one-for-one basis.
F2: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on May 4, 2022.
F3: Reflects shares withheld for taxes payable upon the vesting of RSUs.
F4: The RSUs vested on April 4, 2025.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Thermon Group Holdings, Inc.
Report date June 01, 2026 · Filed June 03, 2026
Section 16 reporting ended · disclosed 2026-06-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-06-01 transaction · row 1
1 source rowRow 1 · 2026-06-01 · Disposition to issuer · Disposed 13,643 · Balance 0 F1: Pursuant to the terms of the Agreement and Plan of Merger dated February 23, 2026 (the "Merger Agreement") by and among the Issuer, CECO Environmental Corp ("CECO"), and two wholly-owned merger subsidiaries of CECO (the "Merger Subs"), the Issuer merged with the two Merger Subs to become a wholly-owned subsidiary of CECO (the "Merger"). F2: Pursuant to the terms of the Merger Agreement, each share of Issuer common stock (other than excluded and dissenting shares) was converted into the right to receive, at the election of the holder, one of the following forms of merger consideration, subject to proration as described in the Merger Agreement: (i) 0.6840 shares of CECO common stock and $10.00 in cash, without interest (the "mixed consideration"), which is the default election; (ii) $63.89 in cash, without interest (the "cash consideration"); or (iii) 0.8110 shares of CECO common stock (the "stock consideration"). The reporting person elected a combination of the mixed consideration and the cash consideration for their shares of Issuer common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the terms of the Agreement and Plan of Merger dated February 23, 2026 (the "Merger Agreement") by and among the Issuer, CECO Environmental Corp ("CECO"), and two wholly-owned merger subsidiaries of CECO (the "Merger Subs"), the Issuer merged with the two Merger Subs to become a wholly-owned subsidiary of CECO (the "Merger").
F2: Pursuant to the terms of the Merger Agreement, each share of Issuer common stock (other than excluded and dissenting shares) was converted into the right to receive, at the election of the holder, one of the following forms of merger consideration, subject to proration as described in the Merger Agreement: (i) 0.6840 shares of CECO common stock and $10.00 in cash, without interest (the "mixed consideration"), which is the default election; (ii) $63.89 in cash, without interest (the "cash consideration"); or (iii) 0.8110 shares of CECO common stock (the "stock consideration"). The reporting person elected a combination of the mixed consideration and the cash consideration for their shares of Issuer common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 04, 2022 Filed May 6, 2022 22:23 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantRestricted Stock Units · Derivative | 1,258 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-006673 · doc4.xml · derivative · entry 3 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,258 Underlying: Common Stock · 1,258 shares Expires 2025-04-04 F3 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F4 · shares: Represents RSUs granted under the Equity Choice Program. Read SEC document |
| May 04, 2022 Filed May 6, 2022 22:23 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantPurchased Restricted Stock Units · Derivative | 503 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-006673 · doc4.xml · derivative · entry 2 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 503 Underlying: Common Stock · 503 shares Expires 2025-04-04 F1 · derivative.exercise_price: The Purchased Restricted Stock Units ("PRSUs") convert to Common Stock on a one-for-one basis. F2 · shares: Represents matching grant of PRSUs under the Equity Choice Program, all of which will vest on April 4, 2025. Read SEC document |
| February 19, 2022 Filed Feb 23, 2022 21:02 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Exercise / conversionRestricted Stock Units · Derivative | 585 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-003048 · doc4.xml · derivative · entry 3 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,266 Underlying: Common Stock · 585 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 19, 2020. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. F4 · derivative.exercise_date: The RSUs vested on February 19, 2022. F4 · derivative.expiration_date: The RSUs vested on February 19, 2022. Read SEC document |
| February 19, 2022 Filed Feb 23, 2022 21:02 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Tax withholdingCommon Stock | 188 | $135.03 | $25,385.64 |
DisclosureSEC source: 0001225208-22-003048 · doc4.xml · nonDerivative · entry 2 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,815 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| February 19, 2022 Filed Feb 23, 2022 21:02 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Exercise / conversionCommon Stock | 585 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-003048 · doc4.xml · nonDerivative · entry 1 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,003 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 19, 2020. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 23:44 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Exercise / conversionRestricted Stock Units · Derivative | 366 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002342 · doc4.xml · derivative · entry 3 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,851 Underlying: Common Stock · 366 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 14, 2019. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. F4 · derivative.exercise_date: The RSUs vested on February 14, 2022. F4 · derivative.expiration_date: The RSUs vested on February 14, 2022. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 23:44 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Tax withholdingCommon Stock | 120 | $132.10 | $15,852.00 |
DisclosureSEC source: 0001225208-22-002342 · doc4.xml · nonDerivative · entry 2 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,418 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 23:44 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Exercise / conversionCommon Stock | 366 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002342 · doc4.xml · nonDerivative · entry 1 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,538 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 14, 2019. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 23:31 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantRestricted Stock Units · Derivative | 2,682 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-000284 · doc4.xml · derivative · entry 3 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,217 Underlying: Common Stock · 2,682 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F2 · derivative.exercise_date: The RSUs will vest in equal tranches with respect to 1,341 shares of Common Stock on each of January 3, 2023 and January 3, 2024, in each case subject to the reporting person's continued employment with the Company. F2 · derivative.expiration_date: The RSUs will vest in equal tranches with respect to 1,341 shares of Common Stock on each of January 3, 2023 and January 3, 2024, in each case subject to the reporting person's continued employment with the Company. Read SEC document |
| December 30, 2021 Filed Jan 4, 2022 23:31 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Exercise / conversionStock Options (right to buy) · Derivative | 3,481 | $0.00 Strike: $115.48 | $0.00 |
DisclosureSEC source: 0001225208-22-000284 · doc4.xml · derivative · entry 2 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,481 shares Expires 2022-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 30, 2021 Filed Jan 4, 2022 23:31 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Exercise / conversionCommon Stock | 3,481 | $115.48 | $401,985.88 |
DisclosureSEC source: 0001225208-22-000284 · doc4.xml · nonDerivative · entry 1 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,172 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2021 Filed May 8, 2021 01:40 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantRestricted Stock Units · Derivative | 518 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-007783 · doc4.xml · derivative · entry 3 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 518 Underlying: Common Stock · 518 shares Expires 2024-04-05 F3 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F4 · shares: Represents RSUs granted under the Equity Choice Program. Read SEC document |
| May 05, 2021 Filed May 8, 2021 01:40 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantPurchased Restricted Stock Units · Derivative | 622 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-007783 · doc4.xml · derivative · entry 2 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 622 Underlying: Common Stock · 622 shares Expires 2024-04-05 F1 · derivative.exercise_price: The Purchased Restricted Stock Units ("PRSUs") convert to Common Stock on a one-for-one basis. F2 · shares: Represents matching grant of PRSUs under the Equity Choice Program, all of which will vest on April 5, 2024. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 22:34 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Exercise / conversionRestricted Stock Units · Derivative | 584 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-003540 · doc4.xml · derivative · entry 3 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,535 Underlying: Common Stock · 584 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 19, 2020. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. F4 · derivative.exercise_date: The RSUs vested on February 19, 2021. F4 · derivative.expiration_date: The RSUs vested on February 19, 2021. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 22:34 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Tax withholdingCommon Stock | 192 | $139.24 | $26,734.08 |
DisclosureSEC source: 0001225208-21-003540 · doc4.xml · nonDerivative · entry 2 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 691 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 22:34 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Exercise / conversionCommon Stock | 584 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-003540 · doc4.xml · nonDerivative · entry 1 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 883 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 19, 2020. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| February 15, 2021 Filed Feb 18, 2021 02:14 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Exercise / conversionRestricted Stock Units · Derivative | 81 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002881 · doc4.xml · derivative · entry 6 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 81 shares Expires 2021-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F4 · shares: Reflects vesting and settlement of RSUs granted on February 15, 2018. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| February 15, 2021 Filed Feb 18, 2021 02:14 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Tax withholdingCommon Stock | 27 | $136.21 | $3,677.67 |
DisclosureSEC source: 0001225208-21-002881 · doc4.xml · nonDerivative · entry 4 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| February 15, 2021 Filed Feb 18, 2021 02:14 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Exercise / conversionCommon Stock | 81 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002881 · doc4.xml · nonDerivative · entry 3 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Reflects vesting and settlement of RSUs granted on February 15, 2018. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| February 14, 2021 Filed Feb 18, 2021 02:14 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Exercise / conversionRestricted Stock Units · Derivative | 365 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002881 · doc4.xml · derivative · entry 5 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,356 Underlying: Common Stock · 365 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 14, 2019. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. F5 · derivative.exercise_date: The RSUs vested on February 14, 2021. F5 · derivative.expiration_date: The RSUs vested on February 14, 2021. Read SEC document |
| February 14, 2021 Filed Feb 18, 2021 02:14 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Tax withholdingCommon Stock | 120 | $136.21 | $16,345.20 |
DisclosureSEC source: 0001225208-21-002881 · doc4.xml · nonDerivative · entry 2 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| February 14, 2021 Filed Feb 18, 2021 02:14 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Exercise / conversionCommon Stock | 365 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002881 · doc4.xml · nonDerivative · entry 1 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 365 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 14, 2019. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| February 14, 2021 Filed Feb 20, 2021 00:00 UTC Amendment | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Exercise / conversionRestricted Stock Units · Derivative | 365 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-003226 · doc4a.xml · derivative · entry 1 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,119 Underlying: Common Stock · 365 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F2 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 14, 2019. F1 · price: The RSUs convert to Common Stock on a one-for-one basis. F3 · derivative.exercise_date: The RSUs vested on February 14, 2021. F3 · derivative.expiration_date: The RSUs vested on February 14, 2021. F4 · balance_after: Number of RSUs was misreported due to administrative error. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 22:58 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantStock Options (right to buy) · Derivative | 10,443 | Not disclosed Strike: $115.48 | Not disclosed |
DisclosureSEC source: 0001225208-21-001614 · doc4.xml · derivative · entry 7 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,443 Underlying: Common Stock · 10,443 shares Expires 2022-02-03 F5 · price: In connection with the Transactions, DuPont options were replaced with Options to purchase Common Stock. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 22:58 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantStock Options (right to buy) · Derivative | 6,375 | Not disclosed Strike: $123.76 | Not disclosed |
DisclosureSEC source: 0001225208-21-001614 · doc4.xml · derivative · entry 6 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,375 Underlying: Common Stock · 6,375 shares Expires 2027-02-01 F5 · price: In connection with the Transactions, DuPont options were replaced with Options to purchase Common Stock. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 22:58 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantStock Options (right to buy) · Derivative | 7,764 | Not disclosed Strike: $77.16 | Not disclosed |
DisclosureSEC source: 0001225208-21-001614 · doc4.xml · derivative · entry 5 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,764 Underlying: Common Stock · 7,764 shares Expires 2030-02-18 F5 · price: In connection with the Transactions, DuPont options were replaced with Options to purchase Common Stock. F6 · derivative.exercise_date: Options will vest and become exercisable in three equal tranches with respect to 2,588 shares of Common Stock on each of February 19, 2021, 2022 and 2023, subject to continued employment with IFF. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 22:58 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantStock Options (right to buy) · Derivative | 3,138 | Not disclosed Strike: $149.65 | Not disclosed |
DisclosureSEC source: 0001225208-21-001614 · doc4.xml · derivative · entry 4 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,138 Underlying: Common Stock · 3,138 shares Expires 2028-02-14 F5 · price: In connection with the Transactions, DuPont options were replaced with Options to purchase Common Stock. F4 · derivative.exercise_date: Option is exercisable as of the date of replacement with respect to 2,092 shares of Common Stock. The Option will become exercisable in respect of the remaining 1,046 shares of Common Stock on February 15, 2021, subjet to continued employment with IFF. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 22:58 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantRestricted Stock Units · Derivative | 81 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001225208-21-001614 · doc4.xml · derivative · entry 3 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81 Underlying: Common Stock · 81 shares Expires 2021-02-15 F1 · derivative.exercise_price: In connection with the combination of IFF and the Nutrition & Biosciences business ("N&B") of DuPont de Nemours, Inc. ("DuPont") (the "Transactions"), DuPont restricted stock units were replaced with Restricted Stock Units ("RSUs") that convert into Common Stock on a one-for-one basis upon vesting. F1 · price: In connection with the combination of IFF and the Nutrition & Biosciences business ("N&B") of DuPont de Nemours, Inc. ("DuPont") (the "Transactions"), DuPont restricted stock units were replaced with Restricted Stock Units ("RSUs") that convert into Common Stock on a one-for-one basis upon vesting. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 22:58 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantRestricted Stock Units · Derivative | 1,462 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001225208-21-001614 · doc4.xml · derivative · entry 2 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,721 Underlying: Common Stock · 1,462 shares Expires not disclosed F1 · derivative.exercise_price: In connection with the combination of IFF and the Nutrition & Biosciences business ("N&B") of DuPont de Nemours, Inc. ("DuPont") (the "Transactions"), DuPont restricted stock units were replaced with Restricted Stock Units ("RSUs") that convert into Common Stock on a one-for-one basis upon vesting. F1 · price: In connection with the combination of IFF and the Nutrition & Biosciences business ("N&B") of DuPont de Nemours, Inc. ("DuPont") (the "Transactions"), DuPont restricted stock units were replaced with Restricted Stock Units ("RSUs") that convert into Common Stock on a one-for-one basis upon vesting. F3 · derivative.exercise_date: RSUs vest with respect to 731 shares of Common Stock on each of February 14, 2021 and 2022, subject to continued employment with IFF. F3 · derivative.expiration_date: RSUs vest with respect to 731 shares of Common Stock on each of February 14, 2021 and 2022, subject to continued employment with IFF. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 22:58 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantRestricted Stock Units · Derivative | 5,259 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001225208-21-001614 · doc4.xml · derivative · entry 1 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,259 Underlying: Common Stock · 5,259 shares Expires not disclosed F1 · derivative.exercise_price: In connection with the combination of IFF and the Nutrition & Biosciences business ("N&B") of DuPont de Nemours, Inc. ("DuPont") (the "Transactions"), DuPont restricted stock units were replaced with Restricted Stock Units ("RSUs") that convert into Common Stock on a one-for-one basis upon vesting. F1 · price: In connection with the combination of IFF and the Nutrition & Biosciences business ("N&B") of DuPont de Nemours, Inc. ("DuPont") (the "Transactions"), DuPont restricted stock units were replaced with Restricted Stock Units ("RSUs") that convert into Common Stock on a one-for-one basis upon vesting. F2 · derivative.exercise_date: RSUs vest in three equal tranches with respect to 1,753 shares of Common Stock on each of February 19, 2021, 2022 and 2023, subject to continued employment with IFF. F2 · derivative.expiration_date: RSUs vest in three equal tranches with respect to 1,753 shares of Common Stock on each of February 19, 2021, 2022 and 2023, subject to continued employment with IFF. Read SEC document |
| February 01, 2021 Filed Feb 19, 2021 23:56 UTC Amendment | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantStock Options (right to buy) · Derivative | 3,481 | Not disclosed Strike: $115.48 | Not disclosed |
DisclosureSEC source: 0001225208-21-003223 · doc4a.xml · derivative · entry 6 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,481 Underlying: Common Stock · 3,481 shares Expires 2022-02-03 F5 · shares: Number of Options was misreported due to administrative error. F7 · price: In connection with the Transactions, DuPont options were replaced with Options to purchase Common Stock. Read SEC document |
| February 01, 2021 Filed Feb 19, 2021 23:56 UTC Amendment | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantStock Options (right to buy) · Derivative | 2,125 | Not disclosed Strike: $123.76 | Not disclosed |
DisclosureSEC source: 0001225208-21-003223 · doc4a.xml · derivative · entry 5 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,125 Underlying: Common Stock · 2,125 shares Expires 2027-02-01 F5 · shares: Number of Options was misreported due to administrative error. F7 · price: In connection with the Transactions, DuPont options were replaced with Options to purchase Common Stock. Read SEC document |
| February 01, 2021 Filed Feb 19, 2021 23:56 UTC Amendment | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantStock Options (right to buy) · Derivative | 2,588 | Not disclosed Strike: $77.16 | Not disclosed |
DisclosureSEC source: 0001225208-21-003223 · doc4a.xml · derivative · entry 4 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,588 Underlying: Common Stock · 2,588 shares Expires 2030-02-18 F5 · shares: Number of Options was misreported due to administrative error. F7 · price: In connection with the Transactions, DuPont options were replaced with Options to purchase Common Stock. F8 · derivative.exercise_date: Options will vest and become exercisable in three equal tranches on each of February 19, 2021, 2022 and 2023, subject to continued employment with IFF. Read SEC document |
| February 01, 2021 Filed Feb 19, 2021 23:56 UTC Amendment | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantStock Options (right to buy) · Derivative | 1,046 | Not disclosed Strike: $149.65 | Not disclosed |
DisclosureSEC source: 0001225208-21-003223 · doc4a.xml · derivative · entry 3 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,046 Underlying: Common Stock · 1,046 shares Expires 2028-02-14 F5 · shares: Number of Options was misreported due to administrative error. F7 · price: In connection with the Transactions, DuPont options were replaced with Options to purchase Common Stock. F6 · derivative.exercise_date: Option is exercisable as of the date of replacement with respect to 696 shares of Common Stock. The Option will become exercisable in respect of the remaining 350 shares of Common Stock on February 15, 2021, subject to continued employment with IFF. Read SEC document |
| February 01, 2021 Filed Feb 19, 2021 23:56 UTC Amendment | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantRestricted Stock Units · Derivative | 731 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001225208-21-003223 · doc4a.xml · derivative · entry 2 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,484 Underlying: Common Stock · 731 shares Expires not disclosed F1 · derivative.exercise_price: In connection with the combination of IFF and the Nutrition & Biosciences business ("N&B") of DuPont de Nemours, Inc. ("DuPont") (the "Transactions"), DuPont restricted stock units were replaced with Restricted Stock Units ("RSUs") that convert into Common Stock on a one-for-one basis upon vesting. F2 · shares: Number of RSUs was misreported due to administrative error. F1 · price: In connection with the combination of IFF and the Nutrition & Biosciences business ("N&B") of DuPont de Nemours, Inc. ("DuPont") (the "Transactions"), DuPont restricted stock units were replaced with Restricted Stock Units ("RSUs") that convert into Common Stock on a one-for-one basis upon vesting. F4 · derivative.exercise_date: RSUs vest in two equal tranches on each of February 14, 2021 and 2022, subject to continued employment with IFF. F4 · derivative.expiration_date: RSUs vest in two equal tranches on each of February 14, 2021 and 2022, subject to continued employment with IFF. Read SEC document |
| February 01, 2021 Filed Feb 19, 2021 23:56 UTC Amendment | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantRestricted Stock Units · Derivative | 1,753 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001225208-21-003223 · doc4a.xml · derivative · entry 1 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,753 Underlying: Common Stock · 1,753 shares Expires not disclosed F1 · derivative.exercise_price: In connection with the combination of IFF and the Nutrition & Biosciences business ("N&B") of DuPont de Nemours, Inc. ("DuPont") (the "Transactions"), DuPont restricted stock units were replaced with Restricted Stock Units ("RSUs") that convert into Common Stock on a one-for-one basis upon vesting. F2 · shares: Number of RSUs was misreported due to administrative error. F1 · price: In connection with the combination of IFF and the Nutrition & Biosciences business ("N&B") of DuPont de Nemours, Inc. ("DuPont") (the "Transactions"), DuPont restricted stock units were replaced with Restricted Stock Units ("RSUs") that convert into Common Stock on a one-for-one basis upon vesting. F3 · derivative.exercise_date: RSUs vest in three equal tranches on each of February 19, 2021, 2022 and 2023, subject to continued employment with IFF. F3 · derivative.expiration_date: RSUs vest in three equal tranches on each of February 19, 2021, 2022 and 2023, subject to continued employment with IFF. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.